
Figure 1. Pharmaceutical areas with an AI footprint
“… 60 use cases and 36 companies or institutions expanding their activities in different pharmaceutical areas.”
* Our review was limited to publications and corporate communications in 2019 and later, hence this is a non-exhaustive list of industry developments. If you would like to add a use case or company relevant to AI applications in the pharmaceutical domain, please do not hesitate to contact us at contact@datascience.ch

Drug Discovery and Development
“… biomarker discovery with data science tools that can ensure their sensitivity, robustness and validate results…”

Operational Optimization
“A continuous medical follow up history generates a multitude of personalized data…”

Personalized Medicine

Gene Editing
“AI can make gene editing initiatives more accurate, safer and cheaper.”

Disease Diagnosis
“Unsupervised learning could change the way diseases are classified, as current disease ontologies were created in a top-down fashion based on the observed symptoms.”
Summary
“The most common use case (based on the number of involved companies) is compound screening for their affinity and toxicity.”

Figure 2. Frequency graph of AI use cases attributed to pharma companies or academic institutions. Node size corresponds to the number of attributable interactions. Green nodes indicate use case names and red nodes correspond to different players on the market.
Disclaimer: The network depiction of the use cases and participating companies was limited to publications and corporate communications in 2019 and later, hence this is a non-exhaustive list of industry developments. If you would like to add a use case or company relevant to AI applications in the pharmaceutical domain, please do not hesitate to contact at contact@datascience.ch
- Shaywitz D. (2019) “Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It’s So Hard”.
- Data Revenue (2019) “Artificial Intelligence in Medicine”.
- de Jesus A. (2019) “Artificial Intelligence in the Pharmaceutical Industry – An Overview of Innovations”.
- Yeadon N. (2019) “Artificial Intelligence in Pharma”.
- Conroy D., Conroy M. (2019) “AI in Pharmaceuticals”.
- Proffitt C. (2017) “Top 10 Artificial Intelligence Companies Disrupting the Pharmaceutical Industry”.
- Arsene C. (2019) “Artificial Intelligence & Pharma: What’s Next?”.
- PharmaTutor (2019) “TOP 10 Pharmaceutical industries using Artificial Intelligence (AI)”.
- Sennaar K. (2019) “AI in Pharma and Biomedicine – Analysis of the Top 5 Global Drug Companies”.
- Liu A. (2018) “Making CRISPR-Cas9 gene editing safer with artificial intelligence”.